Delayed total release two pulse gastrointestinal drug delivery system

• US 6,632,451 B2
• Filed: 06/04/1999
• Issued: 10/14/2003
• Est. Priority Date: 06/04/1999
• Status: Expired due to Fees

• Current Assignee: Dexcel Pharma Technologies (Dexcel Limited)
• Original Assignee: Dexcel Pharma Technologies (Dexcel Limited)
• Inventors: Penhasi, Adel, Lerner, E. Itzhak, Flashner, Moshe
• Primary Examiner(s): Page, Thurman K.
• Assistant Examiner(s): CHANNAVAJJALA, LAKSHMI SARADA
• Application Number:
  US09/325,748
• Publication Number:
  US 20020110593A1
• Time in Patent Office: 1,593 Days
• Field of Search: 424/464, 424/465, 424/468, 424/471, 424/473, 424/474, 424/479-482, 424/484-489
• US Class Current: 424/464
• CPC Class Codes: A61K 9/209 containing drug in at least two layers or in the core and in at least one outer layer
• CPC Class Codes: A61K 9/286 Polysaccharides, e.g. gums; Cyclodextrin
• CPC Class Codes: Y10S 977/906 Drug delivery

Abstract

A two pulse gastrointestinal delivery system is provided. The system comprises a desired agent in combination with a swellable core material, the core being surrounded by an inner coat of a water-insoluble or relatively water-insoluble coating material in which particulate water-insoluble material is embedded. The inner coat is additionally surrounded by an outer coat that contains additional amounts of the desired agent. When the delivery device enters the gastrointestinal tract, the outer coat releases the desired agent contained therein and disintegrates, exposing the inner coat. The particulate matter in the inner coat takes up liquid, thus forming channels interconnecting the drug-containing core with the outside of the delivery device. Through these channels liquid enters the core which then swells to the point at which the inner coat is broken. When the integrity of the inner coat is destroyed, the core then disintegrates, immediately releasing all or most of the drug at a specific site. By controlling parameters in the device, such as the core material, carrier material in the coating, and particulate matter, the location of release of both pulses of the drug can be carefully controlled. The invention is also directed to a method of using the device for the treatment of disease by the release of drugs in the gastrointestinal tract in a location- and time-dependent manner.

Claims

1. A two pulse delivery device for delivering one or more active agents to the gastrointestinal tract of a subject in need of the same, wherein said device comprises:

a. a core comprising said one or more active agents and a core material that swells in the presence of an aqueous liquid;

b. an inner coat that surrounds said core, wherein said inner coat has an outer surface and comprises water-insolubic hydrophilic particulate matter embedded in a water-insoluble carrier such that in the presence of an aqueous liquid, said particulate matter forms channels in said inner coat that interconnect said core with said outer surface of said inner coat and wherein said inner coat bursts when said core is swollen, thereby releasing said one or more activc agents from said core, wherein said water-insoluble hydrophilic particulate matter and said water-insoluble carrier both include at least one polyssacharide, and wherein said inner coat does not contain an active agent; and

c. an outer coat that surrounds said outer surface of said inner coat, wherein said outer coat comprises one or more active agents which may be identical to or different from the one or more active agents that are present in said core, said outer coat comprising at least one excipient for controlling release of said one or more active agents and at least one polysaccharide;

wherein release of said one or more active agents from said core and release of said one or more active agents from said outer coat are separated by a predetermined period of time, controlled according to at least a thickness of said inner coat and a relative concentration of said water-insoluble hydrophilic particulate matter of said inner coat.

2. The device of claim 1, wherein said outer coat is further coated with an enteric coating for delaying initiation of release of said one or more agents from said outer coat until the device enters said upper small intestine.

3. The device of claim 1, wherein said polysaccharide of said particulate matter comprises at least one polysaccharide selected from the group consisting of a water-insoluble polysaccharide, a water-insoluble cross-linked polysaccharide, a water-insoluble polysaccharide metal salt and a polysaccharide rendered insoluble by interaction with a poly-cation or poly-anion.

4. The device of claim 1, wherein said core further comprises a disintegrant, and wherein said inner coat is relatively rigid, such that said core disintegrates after said inner coat bursts.

5. The delivery device of claim 4, further comprising a high osmotic gradient across said coating for enhancing uptake of said liquid to said core.

6. The delivery device of claim 4, wherein said core further comprises a hardness enhancer.

7. The delivery device of claim 4, wherein said core material comprises a swellable, non-hydrogel forming water insoluble polymer.

8. The delivery device of claim 4, wherein said relative rigidity of said coating is such that the area under the stress-strain curve of units of energy per area of coating where said coating does not tear is in a range of from about 0.009 to about 0.21 MPa.

9. The delivery device of claim 4, wherein said swellable core material includes at least one derivative of cellulose.

10. The device of claim 9, wherein said at least one derivative of cellulose is selected from the group consisting of cross linked polyvinylpyrrolidone (crospovidone), crosslinked caboxymethylcellulose sodium (cross carmellose), pregelatinized starch, and sodium carboxymethyl starch.

11. The device of claim 1, wherein said swellable core comprises microcrystalline cellulose and a disintegrant.

12. The device of claim 1, wherein said swellable core comprises microcrystalline cellulose and cross linked polyvinylpyrrolidone.

13. The device of claim 12, wherein a ratio of microcrystalline cellulose and cross linked polyvinylpyrrolidone is in a range of from about 1:

1 to about 10;

1.

14. The device of claim 1, wherein said swellable core comprises microcrystalline cellulose and cross linked carboxymethycellulose sodium.

15. The device of claim 1, wherein said swellable core further comprises an absorption enhancer.

16. The device of claim 1, wherein said water-insoluble hydrophilic particulate matter further comprises an insoluble metal salt of pectin.

17. The device of claim 16, wherein said insoluble metal salt of pectin is selected from the group consisting of calcium pectinate, zinc pectinate, aluminum pectinate, ferric pectinate and ferrous pectinate.

18. A method of delivering an active agent to the gastrointestinal tract of a subject, wherein said method comprises oral administration of a two pulse delivery device for delivery of one or more active agents to said gastrointestinal tract of said animal, said device comprising:

a. a core comprising said one or more active agents and a core material that swells in the presence of an aqueous liquid;

b. an inner coat that surrounds said core, wherein said inner core has an outer surface and comprises water-insoluble hydrophilic particulate matter embedded in a water-insoluble carrier such that in the presence of an aqueous liquid, said particulate matter forms channels in said inner coat that interconnect said core with said outer surface of said inner coat and wherein said inner coat bursts when said core is swollen, thereby releasing said one or more active agents from said core, wherein said water-insoluble hydrophilic particulate matter and said water-insoluble carrier both include at least one polysaccharide, and wherein said inner coat does not contain an active agent; and

c. an outer coat that surrounds said outer surface of said inner coat, wherein said outer coat comprises one or more active agents which may be identical to or different from the one or more active agents that arc present in said core, said outer coat comprising at least one excipient for controlling release of said one or more active agents, wherein said water-insoluble hydrophilic particulate matter and said water-insoluble carrier both include at least one polysaccharide;

wherein release of said one or more active agents from said core and release or said one or more active agents from said outer coat are separated by a predetermined period of time, controlled according to at least a thickness of said inner coat and a relative concentration of said water-insoluble hydrophilic particulate matter of said inner coat.

19. The method of claim 18, wherein said outer coat is further coated with an enteric coating for delaying initiation of release of said one or more agents from said outer coat until said device enters said upper small intestine.

20. The method of claim 18, wherein said polysaccharide of said particulate matter comprises at least one polysaccharide selected from the group consisting of a water-insoluble polysaccharide, a water-insoluble cross-linked polysaccharide, a water-insoluble polysaccharide metal salt and a polysaccharide rendered insoluble by interaction with a poly-cation or poly-anion.

21. The method of claim 18, wherein said core further comprises a disintegrant, and wherein said inner coat is relatively rigid, such that said core disintegrates after said inner coat bursts.

22. The method of claim 19, further comprising a high osmotic gradient across said coating for enhancing uptake of said liquid to said core.

23. The method of claim 19, wherein said core further comprises a hardness enhancer.

24. The method of claim 18, wherein said core material comprises a swellable, non-hydrogel forming water insoluble polymer.

25. The method of claim 18, wherein said relative rigidity of said coating is such that the area under the stress-strain curve of units of energy per area of coating where said coating does not tear is in a range of from about 0.009 to about 0.21 MPa.

26. The method of claim 18, wherein said swellable core material includes at least one derivative of cellulose.

27. The method of claim 26, wherein said at least one derivative of cellulose is selected from the group consisting of cross linked polyvinylpyrrolidone (crospovidone), crosslinked caboxymethylcellulose sodium (cross carmellose), pregelatinized starch, and sodium carboxymethyl starch.

28. The method of claim 18, wherein said swellable core comprises microcrystalline cellulose and a disintegrant.

29. The method of claim 18, wherein said swellable core comprises microcrystalline cellulose and cross linked polyvinylpyrrolidone.

30. The method of claim 29, wherein a ratio of microcrystalline cellulose and cross linked polyvinylpyrrolidone is in a range of from about 1:

1 to about 10;

1.

31. The method of claim 18, wherein said swellable core comprises microcrystalline cellulose and cross linked carboxymethylcellulose sodium.

32. The method of claim 18, wherein said swellable core further comprises an absorption enhancer.

33. The method of claim 18, wherein said water-insoluble hydrophilic particulate matter further comprises an insoluble metal salt of pectin.

34. The method of claim 18, wherein said insoluble metal salt of pectin is selected from the group consisting of calcium pectinate, zinc pectinate, aluminum pectinate, ferric pectinate and ferrous pectinate.

35. The method of claim 18, wherein said active agent is selected from the group consisting of a non-steroidal anti-inflammatory agent (NSAID), a steroid, a contraceptive, a steroidal hormone, an immunosuppressant, a bronchodilator, an anti-anginal, an anti-hypertensive, an anti-spasmodic agent, an anti-colitis agent, an anti-arrhythmia agent, an anti-neoplastic agent, a protein, a peptide, a hormone, a vaccine, an anti-coagulant, an anti-migraine agent, glibenclamide, a 5-hydroxytryptamine type 1A receptor agonist, a 5HT3 antagonist, metkepyhamid, menthol, an antibiotic, a prostaglandin E1 analog, a prokinetic drug, a cholinergic agonist, a dopamine antagonist, and a reversible inhibitor of acetylcholinesterase.

36. A two pulse delivery device for delivering one or more active agents to the gastrointestinal tract of a subject in need of the same, wherein said device comprises:

a. a core comprising said one or more active agents and a core material that swells in the presence of an aqueous liquid;

b. an inner coat that surrounds said core, wherein said inner core does not contain a drug and wherein said inner core has an outer surface and comprises water-insoluble hydrophilic particulate matter embedded in a water-insoluble carrier such that in the presence of an aqueous liquid, said particulate matter forms channels in said inner coat that interconnect said core with said outer surface of said inner coat for controlling the entry of aqueous liquid to said core, and wherein said inner coat bursts when said core is swollen, thereby releasing said one or more active agents from said core, such that said inner coat controls release of said one or more active agents from said core, wherein said water-insoluble hydrophilic particulate matter and said water-insoluble carrier both include at least one polysaccharide, and wherein said inner coat does not contain an active agent; and

c. an outer coat that surrounds said outer surface of said inner coat, wherein said outer coat comprises one or more active agents which may be identical to or different from the one or more active agents that are present in said core, said outer coat comprising at least one excipient for controlling release or said one or more active agents and at least one polysaccharide, wherein said inner coat physically separates said outer coat from said inner core;

wherein release of said one or more active agents from said core and release of said one or more active agents from said outer coat are separated by a predetermined period of time, controlled according to at least a thickness of said inner coat and a relative concentration of said water-insoluble hydrophilic particulate matter of said inner coat, and such that release of said one or more active agents from said outer coat is controlled separately from said release of said one or more active agents from said core.